Otrivin Ukonserveret (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride is a selective alpha‑adrenergic agonist. When sprayed into the nose it activates alpha‑1 receptors on nasal blood vessels, causing vasoconstriction, reduced swelling of the mucosa, and decreased fluid secretion, which opens the airway.

The exact dose and frequency are determined by the prescribing clinician based on the patient’s age, condition, and response. Typically, a few sprays per nostril are used, but the prescriber’s instructions must always be followed.

Safety in pregnancy and lactation has not been fully established. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

Enquiries are submitted via the product page on gnhindia.com. Provide the required quantity and institutional credentials. GNH India’s team will verify the information, then respond with pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Xylometazoline is a topical alpha‑adrenergic agonist, offering rapid relief with minimal systemic absorption. Compared with oral decongestants, it acts locally, reducing the risk of systemic side effects, but it shares the same caution about limited‑duration use to avoid rebound congestion.

Store the nasal spray at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the cap is tightly closed to maintain product integrity.

The product is administered as a nasal spray. The user tilts the head slightly forward, inserts the nozzle into one nostril, and sprays the prescribed number of actuations while breathing in gently. The procedure is repeated in the other nostril if directed by the prescriber.

Serious risks include rebound nasal congestion (rhinitis medicamentosa) after prolonged use, severe hypertension, and rare allergic reactions such as angioedema. Patients should discontinue use and seek medical attention if they experience any of these symptoms.

Individuals with known hypersensitivity to Xylometazoline or any component of the formulation should avoid the product. It is also contraindicated in patients with severe hypertension, coronary artery disease, or those taking monoamine oxidase inhibitors unless approved by a physician.